PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
This Quarter Return
+22.65%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.26B
AUM Growth
+$1.26B
(+10%)
Cap. Flow
-$21.8M
Cap. Flow
% of AUM
-1.72%
Top 10 Holdings %
Top 10 Hldgs %
85.03%
Holding
34
New
1
Increased
1
Reduced
6
Closed
2
Top Buys
| 1 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
$1.76M |
| 2 |
eHealth
EHTH
|
$1.26M |
Top Sells
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$9.96M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$7.21M |
| 3 |
Vanda Pharmaceuticals
VNDA
|
$3.21M |
| 4 |
Prothena Corp
PRTA
|
$1.92M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$895K |
Sector Composition
| 1 | Healthcare | 99.37% |
| 2 | Financials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioMarin Pharmaceuticals
BMRN
$11.2B
| $168M | 13.25% | 1,976,265 -85,108 | -4% | -$7.21M |
|
2
United Therapeutics
UTHR
$13.8B
| $133M | 10.49% | 633,534 -1,272 | -0.2% | -$266K |
|
3
Insmed
INSM
$28.8B
| $126M | 9.95% | 5,840,398 | – | – |
|
|
ABMD
4
DELISTED
Abiomed Inc
ABMD
| $121M | 9.53% | 490,754 -3,643 | -0.7% | -$895K |
|
|
RVNC
5
DELISTED
Revance Therapeutics, Inc.
RVNC
| $119M | 9.4% | 4,405,039 | – | – |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $103M | 8.13% | 9,847,774 | – | – |
|
|
7
Prothena Corp
PRTA
$441M
| $100M | 7.91% | 1,649,777 -31,700 | -2% | -$1.92M |
|
8
Biogen
BIIB
$19.4B
| $96.4M | 7.62% | 360,981 | – | – |
|
9
STAAR Surgical
STAA
$1.36B
| $77.4M | 6.12% | 1,096,882 -9,685 | -0.9% | -$683K |
|
|
SAGE
10
DELISTED
Sage Therapeutics
SAGE
| $33.3M | 2.64% | 851,409 | – | – |
|
11
Karyopharm Therapeutics
KPTI
$61.7M
| $30.7M | 2.43% | 5,621,533 | – | – |
|
12
Acadia Pharmaceuticals
ACAD
$4.38B
| $27.5M | 2.17% | 1,678,196 | – | – |
|
|
13
Vanda Pharmaceuticals
VNDA
$279M
| $21.4M | 1.69% | 2,166,156 -325,044 | -13% | -$3.21M |
|
14
Gossamer Bio
GOSS
$562M
| $21M | 1.66% | 1,750,651 | – | – |
|
15
Syndax Pharmaceuticals
SNDX
$1.41B
| $14.7M | 1.16% | 612,600 | – | – |
|
16
Alkermes
ALKS
$4.78B
| $13.5M | 1.07% | 603,400 | – | – |
|
17
AnaptysBio
ANAB
$569M
| $11M | 0.87% | 431,024 | – | – |
|
18
Align Technology
ALGN
$10.3B
| $9.18M | 0.73% | 44,305 | – | – |
|
|
19
eHealth
EHTH
$118M
| $7.73M | 0.61% | 1,977,993 +323,300 | +20% | +$1.26M |
|
|
GRTS
20
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $5.99M | 0.47% | 2,330,504 | – | – |
|
21
Kezar Life Sciences
KZR
$28.9M
| $5.65M | 0.45% | 656,200 | – | – |
|
22
Cytokinetics
CYTK
$4.23B
| $5.41M | 0.43% | 111,717 | – | – |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $5.32M | 0.42% | 4,473,967 | – | – |
|
24
Travere Therapeutics
TVTX
$1.56B
| $4.09M | 0.32% | 166,069 | – | – |
|
|
PRVB
25
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.76M | 0.14% | +390,800 | New | +$1.76M |
|